Clinical blood sampling for oxylipin analysis – effect of storage and pneumatic tube transport of blood on free and total oxylipin profile in human plasma and serum
Literature Information
Katharina M. Rund, Fabian Nolte, Julian Doricic, Robert Greite, Sebastian Schott, Ralf Lichtinghagen, Faikah Gueler, Nils Helge Schebb
Quantitative analysis of oxylipins in blood samples is of increasing interest in clinical studies. However, storage after sampling and transport of blood might induce artificial changes in the apparent oxylipin profile due to ex vivo formation/degradation by autoxidation or enzymatic activity. In the present study we investigated the stability of free (i.e. non-esterified) and total oxylipins in EDTA-plasma and serum generated under clinical conditions assessing delays in sample processing and automated transportation: Free cytochrome P450 monooxygenase and 5-lipoxygenase (LOX) formed oxylipins as well as autoxidation products were marginally affected by storage of whole blood up to 4 h at 4 °C, while total (i.e. the sum of free and esterified) levels of these oxylipins were stable up to 24 h and following transport. Cyclooxygenase (COX) products (TxB2, 12-HHT) and 12-LOX derived hydroxy-fatty acids were prone to storage and transport induced changes due to platelet activation. Total oxylipin patterns were generally more stable than the concentration of free oxylipins. In serum, coagulation induced higher levels of COX and 12-LOX products showing a high inter-individual variability. Overall, our results indicate that total EDTA-plasma oxylipins are the most stable blood oxylipin marker for clinical samples. Here, storage of blood before further processing is acceptable for a period up to 24 hours at 4 °C. However, levels of platelet derived oxylipins should be interpreted with caution regarding potential ex vivo formation.
Related Literature
Frame-by-frame observations of structure fluctuations in single mass-selected Au clusters using aberration-corrected electron microscopy
Cesare Roncaglia, Diana Nelli, El Yakout El Koraychy, Riccardo Ferrando, Thomas J. A. Slater, Richard E. Palmer
DOI: 10.1039/D3NH00291H
A PEDOT:PSS nanocomposite film doped with black phosphorus modified with silver nanoparticles for wearable photothermoelectric generators
Chia-Hao Tsai, Shih-Hung Tung, Jhih-Min Lin
DOI: 10.1039/D3TA05836K
2D-Ti3C2Tx MXene-supported Cu2S nanoflakes for supercapacitors and electrocatalytic oxygen evolution reaction
Debika Gogoi, Rajeshvari Samatbhai Karmur, Narendra Nath Ghosh
DOI: 10.1039/D3TA05104H
Low-cost and high-performance selenium indoor photovoltaics
Zongbao Li, Mingjie Feng, Bin Yan
DOI: 10.1039/D3TA04530G
Contact engineering for 2D Janus MoSSe/metal junctions
Yu Shu, Ting Li, Naihua Miao, Jian Gou, Xiaochun Huang, Zhou Cui, Rui Xiong, Cuilian Wen, Jian Zhou, Baisheng Sa, Zhimei Sun
DOI: 10.1039/D3NH00450C
Improving the electrochemical performance of Li2S cathodes based on point defect control with cation/anion dual doping
Wenli Pan, Nobuya Machida, Toshiyuki Matsunaga, Mukesh Kumar, Neha Thakur, Toshiki Watanabe, Atsushi Sakuda, Akitoshi Hayashi, Masahiro Tatsumisago, Yoshiharu Uchimoto
DOI: 10.1039/D3TA05426H
Highly effective bifunctional defective cobalt phthalocyanine for photo-involved lithium-oxygen batteries
Yujiao Xia, Xingyu Yu, Yunyun Xu, Xiaoli Fan, Bin Gao, Cheng Jiang, Mingyue Zhang, Xianli Huang, Hao Gong, Jianping He, Tao Wang
DOI: 10.1039/D3TA05032G
Albumin protein encapsulation into a ZIF-8 framework with Co-LDH-based hierarchical architectures for robust catalytic reduction
Maryam Chafiq, Abdelkarim Chaouiki, Tri Suhartono, Young Gun Ko
DOI: 10.1039/D3TA03623E
You might also like
What precautions should be taken when handling lithium chloride hydrate (1:1:1) (CAS: 16712-20-2)?
When handling lithium chloride hydrate (1:1:1) (CAS: 16712-20-2), it is importan...
Is 4-(4H-1,2,4-Triazol-4-yl)piperidine (CAS: 690261-92-8) safe?
4-(4H-1,2,4-Triazol-4-yl)piperidine is generally considered safe for use in phar...
How should waste containing 1,3-Thiazole-2-carboxamide (CAS: 16733-85-0) be handled?
Waste containing 1,3-Thiazole-2-carboxamide (CAS: 16733-85-0) should be collecte...
What regulatory guidelines apply to 5-(Difluoromethyl)-2-fluorobenzonitrile (CAS: 934175-58-3)?
5-(Difluoromethyl)-2-fluorobenzonitrile (CAS: 934175-58-3) is subject to regulat...
How is Methyl 3-acetamido-2-thiophenecarboxylate (CAS: 22288-79-5) typically synthesized?
Methyl 3-acetamido-2-thiophenecarboxylate can be synthesized by the reaction of ...
What is 4-Isoquinolinecarbonitrile (CAS: 34846-65-6)?
4-Isoquinolinecarbonitrile is a chemical compound with the CAS number 34846-65-6...
How should Methyl 1H-1,2,3-triazole-4-carboxylate (CAS: 877309-59-6) be stored?
Store Methyl 1H-1,2,3-triazole-4-carboxylate (CAS: 877309-59-6) in a cool, dry p...
What regulatory guidelines apply to 6-Bromo[1,3]thiazolo[5,4-b]pyridin-2-amine (CAS: 1160791-13-8)?
6-Bromo[1,3]thiazolo[5,4-b]pyridin-2-amine (CAS: 1160791-13-8) is subject to the...
Is (2S,3S)-2-Ammonio-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoate (CAS: 23651-95-8) safe?
(2S,3S)-2-Ammonio-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoate (CAS: 23651-95-8) ...
What are the physical and chemical properties of 7-bromo-3-methyl-3,4-dihydroquinazolin-4-one (CAS: 1293987-84-4)?
7-Bromo-3-methyl-3,4-dihydroquinazolin-4-one is a solid with a crystalline form....
Source Journal
Analyst

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.










![5,10-Dihydroindeno[2,1-a]indene structure 5,10-Dihydroindeno[2,1-a]indene structure](https://static.chemtradehub.com/structs/654/6543-29-9-71ca.webp)



